| Kurt M Walderbach, PT | |
|
250 S Crescent Dr, Mason City, IA 50401-2926 | |
| (641) 422-6995 | |
| (641) 422-6577 |
| Full Name | Kurt M Walderbach |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 38 Years |
| Location | 250 S Crescent Dr, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578696993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 01369 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Synergy Physical Therapy And Sports Medicine Pc | 3476873282 | 7 |
News Archive
University of Adelaide researchers have made a major discovery that highlights the important role played by immune cells in the risk of developing breast cancer.
Purdue University Indianapolis (IUPUI) will host scientists from around the world next week for the first-ever workshop devoted to Distributed Drug Discovery, an innovative, student-driven research program quickly becoming a high-impact, low-cost teaching model.
Tech Collective, Rhode Island's Bioscience and Information Technology industry association, today announces the launch of its 2014 Rhode Island Bioscience Awards.
Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust.
New research from The University of Texas Medical Branch at Galveston indicates that diabetic patients who got their primary care from nurse practitioners did not have an increase in potentially preventable hospital admissions.
› Verified 1 days ago
| Provider Name | Synergy Physical Therapy & Sports Medicine Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1881080984 PECOS PAC ID: 3476873282 Enrollment ID: O20150519001385 |
News Archive
University of Adelaide researchers have made a major discovery that highlights the important role played by immune cells in the risk of developing breast cancer.
Purdue University Indianapolis (IUPUI) will host scientists from around the world next week for the first-ever workshop devoted to Distributed Drug Discovery, an innovative, student-driven research program quickly becoming a high-impact, low-cost teaching model.
Tech Collective, Rhode Island's Bioscience and Information Technology industry association, today announces the launch of its 2014 Rhode Island Bioscience Awards.
Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust.
New research from The University of Texas Medical Branch at Galveston indicates that diabetic patients who got their primary care from nurse practitioners did not have an increase in potentially preventable hospital admissions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kurt M Walderbach, PT 205 W Wacker Dr, Suite 1020, Chicago, IL 60606-1216 Ph: (312) 640-0329 | Kurt M Walderbach, PT 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 422-6995 |
News Archive
University of Adelaide researchers have made a major discovery that highlights the important role played by immune cells in the risk of developing breast cancer.
Purdue University Indianapolis (IUPUI) will host scientists from around the world next week for the first-ever workshop devoted to Distributed Drug Discovery, an innovative, student-driven research program quickly becoming a high-impact, low-cost teaching model.
Tech Collective, Rhode Island's Bioscience and Information Technology industry association, today announces the launch of its 2014 Rhode Island Bioscience Awards.
Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust.
New research from The University of Texas Medical Branch at Galveston indicates that diabetic patients who got their primary care from nurse practitioners did not have an increase in potentially preventable hospital admissions.
› Verified 1 days ago
Kristine Trask, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 520 S Pierce Ave, #224, Mason City, IA 50401 Phone: 641-421-8584 | |
Jared James Johanns, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5255 Fax: 641-494-5259 | |
Joseph S Gullickson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 461 S Illinois Ave, Mason City, IA 50401 Phone: 641-423-6279 Fax: 641-423-6707 | |
Paula M Siems, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-422-6995 Fax: 641-422-6577 | |
Mattison R Munger, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 461 S Illinois Ave, Mason City, IA 50401 Phone: 641-423-6279 | |
Jared James Lichman, DPT, LAT, ATC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 825 S Taft Ave Ste 4, Mason City, IA 50401 Phone: 641-450-0616 | |
Dr. Jeremy Kevin Stamps, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 708-704-4657 |